<DOC>
	<DOCNO>NCT03003975</DOCNO>
	<brief_summary>This clinical study investigator assess efficacy single cryoballoon application per vein guide multipolar record catheter compare conventional technique 2 cryoballoon application pulmonary vein isolation ( PVI ) patient atrial fibrillation ( AF ) .</brief_summary>
	<brief_title>Single Versus Double Cryoballoon Ablation Pulmonary Vein Isolation Patients With Atrial Fibrillation</brief_title>
	<detailed_description>This prospective , randomized clinical study perform one centre . The objective ass efficacy single cryoballoon application per vein guide multipolar record catheter compare conventional technique 2 cryoballoon application pulmonary vein isolation patient atrial fibrillation ( AF ) . 140 subject paroxysmal persistent atrial fibrillation refer first AF ablation procedure enrol . Recruitment , ablation follow-up perform Dep Cardiology Uppsala University Hospital , Uppsala , Sweden . Study duration 2 year 12 -- month enrolment period 1 year follow-up per subject . Pulmonary vein isolation ( PVI ) perform use Arctic Front Advance cryoballoon ablation catheter . Patients randomize single cryoballoon application guide multipolar recording catheter conventional technique 2 cryoballoon application . After cryoballoon ablation pulmonary vein , PV conduction block assess separate circular mapping catheter . Acute procedural success define complete electrical isolation pulmonary vein assess entrance exit block , include 20 minute wait time . Complications duration procedure assess . Patients follow three , six 12 month ablation procedure . A 12 lead ECG , 7 day Holter monitoring , quality life ( EQ5D ) EHRA score , perform baseline , 6 12 month . well Biomarkers include nTproBNP troponin I , perform baseline , 6 12 month ( nTproBNP ) . Predictive variable successful outcome/AF recurrence analyse . The frequency symptomatic recurrence AF number reablations compare 6 12 month , require redo ablation procedure status PV reconduction assess .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Patients paroxysmal persistent AF verify ECG Patients symptom correspond least Europe Heart Rhythm Association ( EHRA ) score 2 . Sinus rhythm maintain least one hour electrical cardioversion . Congestive heart failure New York Heart Association ( NYHA ) class 3 . Left ventricular ejection fraction &lt; 35 % secondary AF inadequate rate control , accord judgement investigator . Left atrial diameter â‰¥ 55 mm judge transthoracic echocardiography . Prior AF ablation procedure . Longstanding persistent AF AF secondary transient correctable abnormality include electrolyte imbalance , trauma , recent surgery , infection , toxic ingestion , uncontrolled thyroid disease well AF trigger uniform supraventricular tachycardia . Contraindication treatment anticoagulant . Significant valvular disease plan cardiac intervention . Hypertrophic cardiomyopathy . Recent cardiac disease state within last 6 month ; unstable angina , acute myocardial infarction , revascularisation procedure , valve disease Implantable cardioverterdefibrillator ( ICD ) , cardiac resynchronization therapy ( CRT ) device . Dual chamber single chamberpacemaker patient pacemaker dependent ventricular level Patients contraindication transseptal catheterization appropriate vascular access preclude . Renal failure require dialysis abnormality liver function test . Participant investigational clinical device trial . Unwilling unable give inform consent inaccessible followup psychological problem might limit compliance . Active abuse alcohol substance may causative AF and/or might affect compliance .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Ablation</keyword>
	<keyword>Cryoballoon</keyword>
	<keyword>Achieve</keyword>
</DOC>